Last Updated: May 6, 2026

ROSUVASTATIN Drug Patent Profile

✉ Email this page to a colleague

When do Rosuvastatin patents expire, and what generic alternatives are available?

Rosuvastatin is a drug marketed by Accord Hlthcare, Alkem Labs Ltd, Amneal Pharms Co, Anvi, Apotex, Aurobindo Pharma Ltd, Biocon Pharma, Cadila Pharms Ltd, Changzhou Pharm, Chartwell Rx, Glenmark Speclt, Hetero Labs Ltd V, Inventia, Lupin, Macleods Pharms Ltd, Mankind Pharma, MSN, Renata, Sandoz, Sciegen Pharms, Shandong, Sun Pharm, Sunshine, Teva Pharms Usa, Torrent, Umedica, Watson Labs Inc, Zhejiang Jingxin, and Zhejiang Yongtai. and is included in twenty-nine NDAs.

The generic ingredient in ROSUVASTATIN is rosuvastatin calcium. There are forty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Rosuvastatin

A generic version of ROSUVASTATIN was approved as rosuvastatin calcium by WATSON LABS INC on April 29^th, 2016.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ROSUVASTATIN?
What are the global sales for ROSUVASTATIN?
What is Average Wholesale Price for ROSUVASTATIN?

Summary for ROSUVASTATIN

US Patents:	0
Applicants:	29
NDAs:	29
Drug Prices:	Drug price information for ROSUVASTATIN
Drug Sales Revenues:	Drug sales revenues for ROSUVASTATIN
DailyMed Link:	ROSUVASTATIN at DailyMed

Drug patent expirations by year for ROSUVASTATIN

US Patents and Regulatory Information for ROSUVASTATIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Renata	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	207062-004	Oct 31, 2016	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Umedica	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	207626-001	Apr 9, 2019	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Glenmark Speclt	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	079172-001	Jul 19, 2016	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Cadila Pharms Ltd	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	207453-004	Nov 23, 2016	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharm	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	079169-002	Jul 19, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Zhejiang Yongtai	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	212059-002	Nov 4, 2019	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Inventia	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	207653-001	Feb 5, 2021		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for ROSUVASTATIN

What are rosuvastatin s intermediate metabolites?
What are the key starting materials for rosuvastatin synthesis?
What is the liver s function in rosuvastatin activation?
Who holds the credit for rosuvastatin s invention?
Who was the original chemist behind rosuvastatin?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.